Related Experiment Videos

Knockout animals in toxicology: assessment of toxin bioactivation pathways using mice deficient in xenobiotic

T Pineau1, P Costet, O Puel

  • 1Laboratoire de Pharmacologie et Toxicologie, INRA, Toulouse, France.

Toxicology Letters
|February 18, 1999
PubMed

Insights

Genetically engineered knockout mice offer enhanced in vivo assessment of toxic pathways. This study uses these models to investigate xenobiotic metabolism and bioactivation by targeting cytochrome P450 genes and the aryl hydrocarbon receptor.

Area of Science:

  • Toxicology and Pharmacology
  • Genetics and Genomics
  • Drug Metabolism

Background:

  • Genetically engineered animal models improve in vivo toxicity assessment.
  • Transgenic mice detect toxic markers from xenobiotic exposure.
  • These models are used for large-scale screening and carcinogenicity testing.

Purpose of the Study:

  • To utilize transgenic knockout mouse lines for accurate investigation of xenobiotic metabolic pathways.
  • To elucidate the role of hepatic metabolic enzymes in xenobiotic bioactivation and bioinactivation.

Main Methods:

  • Employing transgenic knockout mouse lines.
  • Targeting cytochrome P450 (CYP) genes for knockout.
  • Knocking out the aryl hydrocarbon receptor (AHR), a transcriptional activator of CYP genes.

Main Results:

  • Demonstrated the utility of knockout models in studying xenobiotic metabolism.
  • Provided examples of how CYP gene and AHR knockouts affect xenobiotic bioactivation.
  • Highlighted the role of hepatic enzymes in metabolic activation/inactivation.

Conclusions:

  • Transgenic knockout mouse lines are powerful tools for dissecting xenobiotic metabolic pathways.
  • Targeting specific genes like CYP and AHR offers precise insights into drug metabolism and toxicity.
  • This strategy enhances the accuracy of in vivo toxicological assessments.

Related Concept Videos